If you could vote on Brexit now which option would you choose?
   

Novavax delays EU vaccine supply deal amid production problems - source


Novavax is delaying signing a contract to supply its COVID-19 vaccine to the European Union, an EU official involved in the talks told Reuters, as the U.S. biotech company warned it was struggling to source some raw materials. Prolonging the talks might further complicate the EU’s vaccination plans as the bloc had planned to sign a deal early this year for at least 100 million doses of Novavax’s vaccine, with an option for another 100 million. The EU official, who asked not to named as the talks are confidential, said the company had postponed signing a deal for weeks, citing legal issues in meetings with the bloc’s vaccine negotiators. “They are slowing down the process of finishing the contract,” the official, who attended the meetings, told Reuters.

Reuters - March 25, 2021

View the full story here: https://www.reuters.com/article/us-health-coronavirus-eu-novavax-exclusi/exclusive-novavax-delays-eu-vaccine-supply-deal-amid-production-problems-source-idUSKBN2BH2GY